Anna Spreafico

Also affiliated with University of Toronto, Princess Margaret Cancer Centre

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 7 papers. Top paper: “Phase 1 study of the immunotoxin LMB‐100 in patients with mesothelioma and other solid tumors expressing mesothelin”.

Phase 1 study of the immunotoxin LMB‐100 in patients with mesothelioma and other solid tumors expressing mesothelin

Cancer(2020)10.1002/cncr.33145

N/A

0.621DataRank · unranked

62 citations

Christine Alewine, Idrees Mian, Anna Spreafico, Lillian L. Siu, Carlos Gomez‐Roca +13 more

Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab015

N/A

0DataRank · unranked

56 citations

Daniel Shepshelovich, Christina Gallagher, Lisa Wang, Albiruni R. Abdul Razak, Anna Spreafico +5 more

Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy

Nature Immunology(2022)10.1038/s41590-022-01262-7

N/A

0DataRank · unranked

52 citations

Ramy Gadalla, Heidi Elsaesser, Diala Abd-Rabbo, Rene Quevedo, S.Y. Cindy Yang +19 more

Phase Ib study of anetumab ravtansive in combination with immunotherapy or immunotherapy plus chemotherapy in mesothelin-enriched advanced pancreatic adenocarcinoma: NCI10208.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4136

N/A

0DataRank · unranked

12 citations

Anup Kasi, Laith Abushahin, Dana B. Cardin, Heinz‐Josef Lenz, Farshid Dayyani +15 more

Clinical activity of MAPK targeted therapies in patients with non-V600 BRAF mutant tumors

medRxiv(2022)10.1101/2022.02.17.22271120

N/A

0DataRank · unranked

1 citations

Yifan Wang, Rouhi Fazelzad, Benny Johnson, Caroline A. Nebhan, Ibiayi Dagogo‐Jack +24 more

Smoking and alcohol by HPV status in head and neck cancer: a Mendelian randomization study

Nature Communications(2024)10.1038/s41467-024-51679-x

N/A

0DataRank · unranked

42 citations

Jong Wook Lee, Tianzhichao Hou, Katrina Hueniken, Tom Dudding, Mark Gormley +36 more

Genomic landscape of malignant peripheral nerve sheath tumor (MPNST)-like melanoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e22072

N/A

0DataRank · unranked

0 citations

Hadas Sorotsky, Yada Kanjanapan, April A. N. Rose, Daniel Vilarim Araujo, Alexander Fortuna +8 more